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Five-Year Survival Among Medicare Beneﬁciaries Over
Age 80 Undergoing Asymptomatic Carotid
Endarterectomy
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2Harvard School of Public Health, Boston, Mass
Objectives: Beneﬁt from asymptomatic carotid endar-
terectomy (AsCEA) depends on long-term survival. We
undertook this study to examine 5-year survival (5-ys) in
octogenarians after AsCEA.
Methods: National Medicare data from 2006-2011
was used to examine 5-ys in patients aged $80 who un-
derwent elective AsCEA in 2006 without evidence of
TIA or stroke 180 days before surgery. We calculated
overall mortality and used Kaplan-Meier curves to
examine 5-ys. We built Cox proportional hazards
(CPH) models to examine the independent predictors
of survival after AsCEA.
Results: In 2006 16,616 patients aged $80 years un-
derwent AsCEA; 1.3% died #30 days of surgery. Overall,
the probability of 5-ys was 0.56 (95% conﬁdence interval
[CI], 0.55-0.57). A multivariate CPH model identiﬁed
the following comorbidities (COM) as having a signiﬁcant
effect on 5-ys (hazard ratio, 95% CI): COPD (1.45, 1.37-
1.53), CHF (1.90, 1.78-2.03), diabetes (1.10, 1.04-
1.16), renal failure (1.74, 1.62-1.86), and valve disease
(1.23, 1.15-1.32). Age and COM both affected 5-ys,
with the probability of survival ranging from 0.71 (95%
CI, 0.69-0.74) for an 80-year-old (yo) with no COM to
0.18 (95% CI, 0.04-0.38) for a $85-yo with three
COM (P < .01. Conversely, a $85-yo with no COM
had survival superior to an 80-yo with three COM
(0.53 [95% CI, 0.51-0.55] vs 0.34 [95% CI, 0.23-
0.45]; P < .01) (Table).
Conclusions: Although AsCEA may be appropriate
for some older Americans, this study demonstrates that
many octogenarians do not live long enough to derive
beneﬁt. Careful selection is essential.Table. Probability of 5-ys after AsCEA by age and
number of comorbidities
Age, years
No. of Comorbidities
0 1 2 3
Overall 0.64 0.53 0.40 0.29
80 0.71 0.63 0.47 0.34
81 0.71 0.59 0.49 0.42
82 0.69 0.53 0.40 0.31
83 0.67 0.54 0.39 0.33
84 0.65 0.52 0.45 0.25
$85 0.63 0.43 0.32 0.18
All SEs <0.07.
Table. 30-day Results: Early vs Delayed CEA
30-day Results
Overall Early CEA Delayed CEA
P
(n ¼ 322) (n ¼ 100) (n ¼222)
No. (%) No. (%) No. (%)
Death 0 0 0 .
MAE 8 (2.5) 3 (3) 5 (2.2) .7
Any stroke 4 (1.2) 3 (3) 1(0.4) .1
Minor stroke 2 (0.6) 2 (2) 0 .1
Major stroke 2 (0.6) 1 (1)
(Hemorrhagic)
1(0.4)
(Ischemic)
.5
Disabling stroke 2 (0.6) 1 (1) 1 (0.4) .5
Myocardial infarct 4 (1.2) 0 4 (1.8) .3
30-day neurologic status
Improved (decrease
NHISS $1)
43 (13.3) 19 (19) 24 (10.8) .03
Unchanged 275 (85.4) 78 (78) 197 (88.7) .01
Impaired 4 (1.2) 3 (3) 1 (0.4) .1
CEA, Carotid endarterectomy; MAE, major adverse event (composite of
stroke, death, and myocardial infarct); NHISS, National Institutes of Health
Stroke Scale.Author Disclosures: M. Belkin: Nothing to disclose; A. K.
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30-Day Neurologic Improvement Is Associated With
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Objectives: To determine 30-day neurologic improve-
ment (NI) with respect to the timing of carotid endarterec-
tomy (CEA) in symptomatic stable patients.
Methods: Patients included underwent consecutive
CEAs (2009-2013) for symptomatic carotid stenosis
$60%. They had a National Institutes of Health Stroke
Scale (NIHSS) score <5 on presentation. Patients were
divided according to time between the qualifying event
and surgery (0-14 days, n ¼ 100: early CEA; 15-30
days, n ¼ 222: delayed CEA). Outcomes were death,
stroke, myocardial infarct (MI), 30-day major adverse
event (MAE) rate (composite of stroke, death, and
MI), and NI deﬁned as a NIHSS score decrease ($1)
rate at 30 days. Independent neurologic assessment was
performed.
Results: Type of qualifying symptoms (stroke vs tran-
sient ischemic attack) was similar. Early CEA patients had a
higher American Society of Anesthesiologists physical sta-
tus risk (P ¼ .0001) and were more under dual antiplatelet
therapy (P ¼ .02). Outcomes are summarized in the Table.
Thirty-day NI was associated with early CEA (odds ratio,
1.9; 95% conﬁdence interval, 1.0-3.7; P ¼ .03).
Conclusions: Our results suggest that reducing the
time for intervention in selected (NIHSS <5) and stable
symptomatic patients is safe and associated with neurologic
status improvement at 30 days.
